Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
2 Safe Dividend Stocks to Buy Hand Over Fist
01:00pm, Wednesday, 23'rd Nov 2022 The Motley Fool
These businesses may not be "exciting," but that's not such a bad thing right now.
Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?
11:20am, Wednesday, 23'rd Nov 2022 Zacks Investment Research
Style Box ETF report for HDV
This Pharmaceutical Company Is A Better Pick Over Johnson & Johnson Stock
06:00am, Wednesday, 23'rd Nov 2022
While ABBV may outperform JNJ in the next three years, it is helpful to see how Johnson & Johnson's Peers fare on metrics that matter.
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
02:45pm, Tuesday, 22'nd Nov 2022 The Motley Fool
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem.
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
11:20am, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Sector ETF report for FHLC
7 Must-Own Safe Havens as Market Selloff Accelerates
09:02am, Monday, 21'st Nov 2022
Safe haven investments are a great way to lower risk over the long haul. Companies with consistent revenue and earnings tend to be more stable and help significantly lower risk during volatile market
7 Warren Buffet Stocks to Buy and Hold for the Next Decade
07:30am, Monday, 21'st Nov 2022
The reason investors should look for Warren Buffett stocks to buy and hold is that playing the long game is a stable route to success in the stock market. Buffett has proven this over his long investi
7 Top-Rated Large-Cap Stocks to Buy and Hold
09:30pm, Sunday, 20'th Nov 2022
Large-cap stocks are always great to have in a portfolio. These companies are some of the biggest and best-known stocks in the market.
2 Reasons to Buy Pfizer and 1 Reason to Sell
02:37pm, Sunday, 20'th Nov 2022 The Motley Fool
The pharmaceutical company is looking for a future beyond COVID-19 therapies.
Is Your Investment Portfolio Down Big? Consider This Timeless Investing Strategy
12:31pm, Saturday, 19'th Nov 2022 The Motley Fool
The advantages of dividend stocks extend far beyond their passive income stream.
Bear Market Blues? 3 of the Best Stocks to Own in 2023
11:30am, Saturday, 19'th Nov 2022 The Motley Fool
2023 could be a big year for each of these healthcare companies.
Biden: U.S. to purchase an additional 100M doses of J&J vaccine
09:41am, Saturday, 19'th Nov 2022
President Biden hosted the Merck and Johnson & Johnson CEOs at a press conference today. "The partnership between Johnson & Johnson and Merck proves we can do big things, important things in our count
Detroit mayor says he'll accept J&J vaccine after initially turning it down
09:37am, Saturday, 19'th Nov 2022
The mayor of Detroit just clarified his controversial statement about the J&J vaccine. Yesterday, he said he wanted to offer the Pfizer and Moderna vaccines for people, and rejected the J&J vaccine.
J&J's Gorsky and Merck's Frazier on working collaboratively to vaccinate people during pandemic
09:31am, Saturday, 19'th Nov 2022
Johnson & Johnson CEO Alex Gorsky and Merck CEO Ken Frazier discuss the importance of working together during the pandemic to develop an effective vaccine.
Bill Gates: J&J, Novavax vaccines retain 'a lot of capability' against variants
08:59am, Saturday, 19'th Nov 2022
Billionaire Bill Gates said Johnson & Johnson's and Novavax's Covid-19 vaccines will still be essential tools against new, emerging variants of the virus.
